Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Ambulance crews test early antibiotics for sepsis

NCT ID NCT03068741

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether paramedics can improve survival by giving antibiotics and fluids to sepsis patients before reaching the hospital. Over 2,000 adults with suspected sepsis and low blood pressure were enrolled. The goal was to see if early treatment in the field reduces deaths compared to usual care that starts in the emergency department.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ceftriaxone (antibiotic) and intravenous saline (fluids)
What this could lead to
If it works, this could show that starting sepsis treatment in the ambulance saves more lives than waiting until arrival at the hospital.
What could go wrong
This is a completed Phase 4 trial, but the benefit of early paramedic treatment may be small or not apply to all sepsis patients. Risks include allergic reactions to antibiotics or fluid overload.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

2,061 people

The number who actually took part.

Started

Mar 2020

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients with Sepsis, defined as (all 3 must be present): i) Paramedic suspects possible infection: e.g. suspected pneumonia, urinary tract infection, skin infection, bone and joint infection, intra-abdominal infection, meningitis ii) Presence of fever: Temperature ≥ 38.0°C measured by paramedic or history of fever during previous 24 hours iii) Presence of hypotension: Systolic blood pressure \< 100mmHg 2. Age ≥ 18 years Exclusion Criteria: 1. Post cardiac arrest 2. Suspected ST-segment elevation myocardial infarction (STEMI) 3. Suspected acute cerebrovascular accident (CVA) 4. Acute severe trauma 5. Obvious severe non-traumatic bleeding 6. Signs of fluid overload 7. Suspected acute congestive heart failure (CHF) 8. Known Clostridium difficile infection within the last 6 weeks 9. Known pregnancy or breastfeeding 10. Known allergy or sensitivity to penicillin or cephalosporin 11. Known to be receiving oral or subcutaneous anticoagulants or low molecular weight heparin 12. Paramedic is unable to identify patient by first and last name and/or health card number

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Severe sepsis or septic shock are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Halton Region Paramedic Services

    Toronto, Ontario, Canada

  • Peel Region Paramedic Services

    Toronto, Ontario, Canada

  • Toronto Paramedic Services

    Toronto, Ontario, Canada

  • York Region Paramedic Services

    Toronto, Ontario, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.